PathogenDx Lauded by Frost & Sullivan for Its Game-Changing DNA-Based Multiplex Microarray Technology
December 03, 2019
December 03, 2019
SAN ANTONIO, Texas, Dec. 3 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
Based on its recent analysis of the global microbial DNA testing market, Frost & Sullivan recognizes Arizona-based PathogenDx, Inc. with the 2019 Global Technology Innovation Award for its disruptive DNA-based tests. These tests leverage its proprietary and patented . . .
Based on its recent analysis of the global microbial DNA testing market, Frost & Sullivan recognizes Arizona-based PathogenDx, Inc. with the 2019 Global Technology Innovation Award for its disruptive DNA-based tests. These tests leverage its proprietary and patented . . .